Showing results (611-620 of 1,076) with videos related to
Sort By:
Pageof 108
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate CancerElahe A Mostaghel, Brett T Marck, Orpheus Kolokythas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial CancerRandy F Sweis, Gurkamal S Chatta, Rohit K Jain, et al.Clinical Genitourinary Cancer|May 19, 2024
Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder CancerElizabeth L Koehne, Dimitra R Bakaloudi, Fady Ghali, et al.Clinical Genitourinary Cancer|November 27, 2019
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate CancerOrazio Caffo, Michel Wissing, Diletta Bianchini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2022
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative GroupsHeiko Schöder, Thomas A Hope, Michael Knopp, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.Clinical Genitourinary Cancer|June 21, 2023
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy StudyFady Ghali, Funda Vakar-Lopez, Martine P Roudier, et al.The Oncologist|May 11, 2026
A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-Resistant Prostate CancerJulie N Graff, Claire E P Smith, Alexandra O Sokolova, et al.Nature Medicine|June 1, 2024
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trialThomas Powles, Yen-Hwa Chang, Yoshiaki Yamamoto, et al.Cancer Chemotherapy and Pharmacology|January 15, 2013
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, Edwin M Posadas, et al.Pageof 108